Nutraceutical

Women's health

Next from the engine. The gut recycles estrogen and sets its level after menopause; Teroka is mapping the species and networks that do it.

TRI-05 · polyphenol-class gut active

In development, on a US self-affirmed GRAS path, with safety and characterization work underway.

Cosmeceutical

TRI-02 · antioxidant-rich skin active

From the lipid fraction of the same feedstock, on the EU cosmetics pathway. Advancing with a strategic partner.

TRI-06 · skin active

In evaluation.

Partner early

Strategic partners can engage any candidate before launch and shape its format, dose and claims. Talk to us →

How the platform works Talk to us about a candidate
What's the difference between your products and your pipeline?
TRI-01 and TRI-04 are heading to market on defined regulatory pathways; the pipeline spans discovery-stage and in-development candidates without committed launch dates.
Can I partner on a pipeline candidate early?
Yes — strategic partners can engage candidates before launch. Get in touch.
Do you cover cosmeceutical as well as nutraceutical?
Yes — the platform extends into cosmeceutical actives (TRI-02, TRI-06) alongside the nutraceutical line.